NANOVIRICIDES, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Diwan Anil | President | Sale | 15,000 | $1.07 | $16,050 | 7,019,950 | Sep 13, 2011 |
| Diwan Anil | President | Sale | 46,000 | $1.10 | $50,600 | 7,034,950 | Sep 8, 2011 |
| Diwan Anil | President | Sale | 15,000 | $1.06 | $15,900 | 7,111,030 | Sep 7, 2011 |
| Diwan Anil | President | Sale | 30,080 | $1.07 | $32,186 | 7,080,950 | Sep 6, 2011 |
| Diwan Anil | President | Sale | 11,850 | $1.09 | $12,917 | 7,126,030 | Sep 2, 2011 |
| Diwan Anil | President | Sale | 12,625 | $1.08 | $13,635 | 7,148,580 | Aug 29, 2011 |
| Diwan Anil | President | Sale | 13,200 | $1.11 | $14,652 | 7,161,205 | Aug 26, 2011 |
| Diwan Anil | President | Sale | 10,000 | $1.15 | $11,500 | 7,189,405 | Aug 25, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.17 | $5,850 | 7,215,805 | Aug 23, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.18 | $5,900 | 7,235,305 | Aug 19, 2011 |
| Diwan Anil | President | Sale | 18,375 | $1.19 | $21,866 | 7,249,505 | Aug 15, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.06 | $5,300 | 7,294,880 | Aug 11, 2011 |
| Diwan Anil | President | Sale | 44,000 | $1.05 | $46,200 | 7,340,480 | Aug 10, 2011 |
| Diwan Anil | President | Sale | 22,500 | $1.14 | $25,650 | 7,444,480 | Aug 4, 2011 |
| Diwan Anil | President | Sale | 38,000 | $1.22 | $46,360 | 7,488,880 | Aug 3, 2011 |
| Diwan Anil | President | Sale | 7,500 | $1.18 | $8,850 | 7,526,880 | Jul 29, 2011 |
| Diwan Anil | President | Sale | 7,500 | $1.23 | $9,225 | 7,546,880 | Jul 22, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.22 | $6,100 | 7,560,380 | Jul 22, 2011 |
| Diwan Anil | President | Sale | 11,675 | $1.23 | $14,360 | 7,570,380 | Jul 18, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.25 | $6,250 | 7,594,555 | Jul 15, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.28 | $6,400 | 7,599,555 | Jul 12, 2011 |
| Diwan Anil | President | Sale | 10,000 | $1.31 | $13,100 | 7,612,155 | Jul 8, 2011 |
| Diwan Anil | President | Sale | 29,500 | $1.44 | $42,480 | 7,643,155 | Jul 7, 2011 |
| Diwan Anil | President | Sale | 57,000 | $1.40 | $79,800 | 7,672,655 | Jul 1, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.20 | $6,000 | 7,741,155 | Jun 30, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.22 | $6,100 | 7,734,655 | Jun 29, 2011 |
| Diwan Anil | President | Sale | 12,500 | $1.19 | $14,875 | 7,746,155 | Jun 27, 2011 |
| Diwan Anil | President | Sale | 3,500 | $1.28 | $4,480 | 7,795,155 | Jun 23, 2011 |
| Diwan Anil | President | Sale | 10,750 | $1.33 | $14,298 | 7,831,350 | Jun 22, 2011 |
| Diwan Anil | President | Sale | 5,000 | $1.37 | $6,850 | 7,853,100 | Jun 20, 2011 |
| Diwan Anil | President | Gift | 11,100 | $1.38 | $15,318 | 7,871,100 | Jun 16, 2011 |
| Diwan Anil | President | Gift | 2,117,800 | — | — | 7,882,200 | Feb 15, 2011 |
| Seymour Eugene | — | Gift | 2,500,000 | — | — | 6,000,000 | Nov 12, 2010 |
| Theracour Pharma, Inc. | — | Sale | 353,982 | $0.57 | $201,770 | 33,006,018 | Jun 24, 2010 |
| Theracour Pharma, Inc. | — | Sale | 15,000 | $0.88 | $13,200 | 33,572,955 | Dec 1, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.93 | $9,300 | 33,687,000 | Nov 25, 2009 |
| Theracour Pharma, Inc. | — | Sale | 42,500 | $0.89 | $37,825 | 33,697,000 | Nov 20, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.88 | $8,800 | 33,779,500 | Nov 19, 2009 |
| Theracour Pharma, Inc. | — | Sale | 30,000 | $0.87 | $26,100 | 33,799,500 | Nov 17, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.86 | $8,600 | 33,829,500 | Nov 12, 2009 |
| Theracour Pharma, Inc. | — | Sale | 20,000 | $0.85 | $17,000 | 33,859,500 | Nov 10, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.82 | $8,200 | 33,919,500 | Nov 6, 2009 |
| Theracour Pharma, Inc. | — | Sale | 25,000 | $0.83 | $20,750 | 33,929,500 | Nov 5, 2009 |
| Theracour Pharma, Inc. | — | Sale | 30,000 | $0.86 | $25,800 | 33,964,500 | Nov 2, 2009 |
| Theracour Pharma, Inc. | — | Sale | 49,000 | $0.85 | $41,650 | 34,004,500 | Oct 29, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.59 | $5,900 | 34,053,500 | Oct 21, 2009 |
| Theracour Pharma, Inc. | — | Sale | 20,000 | $0.75 | $15,000 | 34,073,500 | Oct 15, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.77 | $7,700 | 34,093,500 | Oct 13, 2009 |
| Theracour Pharma, Inc. | — | Sale | 10,000 | $0.81 | $8,100 | 34,103,500 | Sep 29, 2009 |
| Theracour Pharma, Inc. | — | Sale | 17,500 | $0.88 | $15,400 | 34,163,500 | Sep 28, 2009 |